Shiga, Japan

Yukimitsu Masamoto

This inventor holds 1 USPTO granted patent. Top assignee: Sunstar Kabushiki Kaisha. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yukimitsu Masamoto. Retrieved from https://idiyas.com/inventor/yukimitsu-masamoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yukimitsu Masamoto: Innovator in Pharmaceutical Compositions

Introduction

Yukimitsu Masamoto is a notable inventor based in Shiga, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiallergic compositions. His innovative work has led to the creation of a unique pharmaceutical composition that addresses allergy-related issues.

Latest Patents

Masamoto holds a patent for a pharmaceutical composition aimed at inhibiting histamine release. This composition contains a specific tocopherol derivative that has a sugar residue at the 6-position of the 3,4-dihydrobenzopyrane ring. The patent also discloses a method for producing antiallergic activity using this tocopherol derivative, along with several novel tocopherol derivatives. He has 1 patent to his name.

Career Highlights

Yukimitsu Masamoto is associated with Sunstar Kabushiki Kaisha, a company known for its commitment to health and wellness products. His work at Sunstar has allowed him to focus on innovative solutions in the pharmaceutical sector.

Collaborations

Masamoto has collaborated with notable colleagues, including Toshio Satoh and Hideki Miyataka. These partnerships have contributed to the advancement of his research and the development of effective pharmaceutical solutions.

Conclusion

Yukimitsu Masamoto's contributions to pharmaceutical compositions demonstrate his commitment to innovation in the field of allergy treatment. His work continues to impact the industry positively, paving the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…